help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2235
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/6/3491    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moffett, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moffett, S. P.
Related Collections
Right arrow Calcium and Bone Metabolism
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 6 3491-3497
Copyright © 2005 by The Endocrine Society

Tumor Necrosis Factor-{alpha} Polymorphism, Bone Strength Phenotypes, and the Risk of Fracture in Older Women

S. P. Moffett, J. M. Zmuda, J. I. Oakley, T. J. Beck, J. A. Cauley, K. L. Stone, Li-Yung Lui, K. E. Ensrud, T. A. Hillier, M. C. Hochberg, P. Morin, G. Peltz, D. Greene, S. R. Cummings for the Study of Osteoporotic Fractures Research Group

Department of Epidemiology (S.P.M., J.M.Z., J.I.O., J.A.C.), University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Department of Radiology (T.J.B.), The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196; Department of Medicine (K.L.S., L.-Y.L.), University of California, San Francisco, San Francisco, California 94143; Department of General Internal Medicine (K.E.E.), Veterans Affairs Medical Center, Minneapolis, Minnesota 55417; Kaiser Permanente Center for Health Research Northwest/Hawaii (T.A.H.), Portland, Oregon 97227; Department of Medicine and Epidemiology and Preventive Medicine (M.C.H.), University of Maryland School of Medicine, Baltimore, Maryland 21201; Axys Pharmaceuticals (P.M.), La Jolla, California 92037; Roche Palo Alto (G.P.), Palo Alto, California 94304-1397; Roche Molecular Systems (D.G.), Alameda, California 94588; and Research Institute (S.R.C.), California Pacific Medical Center, San Francisco, California 94120-7999

Address all correspondence and requests for reprints to: Susan P. Moffett, Ph.D., Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, Pennsylvania 15261. E-mail: susan.moffett{at}hgen.pitt.edu.

TNF{alpha} is a proinflammatory cytokine that promotes osteoclastic bone resorption. We evaluated the association between a G-308A polymorphism (rs1800629) at the TNFA locus and osteoporosis phenotypes in 4306 older women participating in the Study of Osteoporotic Fractures. Femoral neck bone mineral density (BMD) and structural geometry were measured using dual-energy x-ray absorptiometry and hip structural analysis. Incident fractures were confirmed by physician adjudication of radiology reports. Despite similar femoral neck BMD, women with the A/A genotype had greater subperiosteal width (P = 0.01) and endocortical diameter (P = 0.03) than those with the G/G genotype. The net result of these structural differences was that there was a greater distribution of bone mass away from the neutral axis of the femoral neck in women with the A/A genotype, resulting in greater indices of bone bending strength (cross-sectional moment of inertia: P = 0.004; section modulus: P = 0.003). Among 376 incident hip fractures during 12.1 yr of follow-up, a 22% decrease in the risk of hip fracture was seen per copy of the A allele (relative risk 0.78; 95% confidence interval 0.63, 0.96), which was not influenced by adjustments for potential confounding factors, BMD, or bone strength indices. The G-308A polymorphism was not associated with a reduced risk of other fractures. These results suggest a potential role of genetic variation in TNF{alpha} in the etiology of osteoporosis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society